Ketamine Hydrochloride Injection — FDA Drug Shortage

No longer listed by FDA — Pfizer Inc.

The FDA lists a drug shortage record for Ketamine Hydrochloride Injection (injection) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Nov 7, 2025.

Shortage details

Status
No longer listed by FDA
Company
Pfizer Inc.
Package NDC
0409-0040-10
Dosage Form
Injection
Presentation
Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)
Initial Posting
Nov 7, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.